All In MedTech

FDA Clearance Tracker · P140031-S064

Sapien 3 Transcatheter Heart Valve

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 26, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 26, 2018

Approved

Time to decision

104 days

Received Apr 13, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P140031-S064
Device name
Sapien 3 Transcatheter Heart Valve
Applicant location
Irvine, CA
Received
Apr 13, 2018
Decided
Jul 26, 2018
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P140031

Device type

Device class
Class III

Every decision under product code NPT

FDA's approval statement

As written in FDA's record.

Approval to remove the precaution regarding patients with a congenital bicuspid aortic valve from the labeling.

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.